AP
WST icon

AHL Partners’s West Pharmaceutical WST Stock Holding History

AHL Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.23M Buy
22,624
+9,380
+71% +$920K 0.03% 688
2017
Q3 		$1.27M Sell
13,244
-11,057
-46% -$1M 0.02% 818
2017
Q2 		$2.3M Buy
24,301
+3,560
+17% +$327K 0.05% 583
2017
Q1 		$1.69M Buy
20,741
+16,081
+345% +$1.34M 0.04% 662
2016
Q4 		$395K Sell
4,660
-11,683
-71% -$919K 0.01% 912
2016
Q3 		$1.22M Buy
16,343
+1,348
+9% +$107K 0.05% 537
2016
Q2 		$1.14M Buy
14,995
+5,453
+57% +$397K 0.06% 401
2016
Q1 		$661K Sell
9,542
-2,340
-20% -$141K 0.04% 497
2015
Q4 		$716K Sell
11,882
-4,699
-28% -$283K 0.06% 407
2015
Q3 		$898K Buy
16,581
+6,602
+66% +$385K 0.14% 223
2015
Q2 		$580K Buy
9,979
+2,420
+32% +$135K 0.02% 655
2015
Q1 		$455K Buy
7,559
+3,202
+73% +$171K 0.02% 654
2014
Q4 		$232K Sell
4,357
-234
-5% -$11.7K 0.01% 709
2014
Q3 		$205K Buy
+4,591
New +$195K 0.02% 684

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

AHL Partners's WST Position: Q4 2017 in Review

AHL Partners increased its West Pharmaceutical (WST) stake by 71% in Q4 2017, buying an estimated $920K and bringing the position to 22,624 shares worth $2.23M. The position accounts for 0.03% of the portfolio, ranked #688.

AHL Partners first reported a position in WST in Q3 2014 and has held it in 14 quarters since. The position peaked at $2.3M in Q2 2017. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

  • AHL Partners held 22,624 shares of West Pharmaceutical worth $2.23M as of Q4 2017.
  • AHL Partners bought 9,380 West Pharmaceutical shares in Q4 2017, an estimated $920K.
  • West Pharmaceutical made up 0.03% of AHL Partners's portfolio in Q4 2017, its #688 holding.
  • AHL Partners first reported a position in West Pharmaceutical in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's West Pharmaceutical position peaked at $2.3M in Q2 2017.
  • 338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.